Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma

SIMPLE SUMMARY: Many solid tumours, such as those of the breast, colon, and prostate, have well established molecular markers of malignancy. However, in certain cancers, such as squamous cell carcinoma (SCC), few clinically useful biomarkers exist. Recently, several candidates that might be used for...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kathryn, Yong, Joel, Zauner, Roland, Wally, Verena, Whitelock, John, Sajinovic, Mila, Kopecki, Zlatko, Liang, Kang, Scott, Kieran Francis, Mellick, Albert Sleiman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688099/
https://www.ncbi.nlm.nih.gov/pubmed/36428658
http://dx.doi.org/10.3390/cancers14225564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688099/
https://www.ncbi.nlm.nih.gov/pubmed/36428658
http://dx.doi.org/10.3390/cancers14225564

Ejemplares similares